Press Releases

Date	Title
11/9/09	AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
11/2/09	AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
10/26/09	AVI BioPharma Presents Updated Safety Data from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
10/22/09	AVI BioPharma to Present Safety Update from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
10/20/09	Exon Skipping Drug Prevents Muscle Wasting and Maintains Muscle Function in Severely Affected, Dystrophin Deficient Mice
10/19/09	Exon Skipping Therapy Shows Promise in Prevention or Delay of Heart Disease Associated with Duchenne Muscular Dystrophy
10/5/09	AVI BioPharma Receives Expanded Contract from U.S. Department of Defense to Develop its Drug Candidate for the Treatment of Junin Virus Infection
9/15/09	AVI BioPharma, Inc. Announces Presentations at Upcoming Investment Conferences
9/14/09	AVI BioPharma, Inc. Demonstrates Effectiveness of Immune Control via RNA-based Therapeutics in Hemorrhagic Virus Infections
9/14/09	AVI BioPharma Presents Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society

IR Menu